Cory berkland
Cory Berkland. Professor. Biomedical Engineering. [email protected]. Google Scholar. Education. PhD, University of Illinois, …Number of Employee Profiles 2. Bond Biosciences has 2 current employee profiles, including Co-founder and Chief Scientific Officer Cory Berkland. Cory Berkland Co-founder and Chief Scientific Officer.
Did you know?
Cory Berkland. The Berkland Lab investigates pharmaceuticals and biomaterials. They aim to understand the transport of pharmaceuticals as a function of physical and chemical properties. Biomaterials are also investigated for applications in regenerative medicine. Faculty Profile. Berkland Research Lab.Corporate Faith - 2023 Business Speakers Series - Cory Berkland. Mon, Aug 14, 6:00 PM. Undivided Experience Center • Chesterfield, MO. Free. Save Corporate Faith - 2023 Business Speakers Series - Cory Berkland to your collection.Berkland Cory [email protected]. Biomaterial(s) Drug delivery system(s) Polymeric biomaterial(s) Polymeric drug delivery system(s) Last Name First Name. Email Address Keywords. Bhambhani Akhilesh [email protected]. Biopharmaceutical characterization. Freeze-drying Gene therapy.liquid droplets (Berkland et al. 2001). A schematic diagram of the PPF nozzle is illustrated in Figure 1. The PLGA/ analyte solution is forced via a syringe pump (New Era Pump Systems, Wantagh, NY) through a 22-gauge hypo-dermic needle at flow rates from 1-10 mL h 1. An annular immiscible stream of water containing a mass concentra-Chad J Pickens 1 , Stephanie N Johnson 1 , Melissa M Pressnall 1 , Martin A Leon 2 , Cory J Berkland 1 2 3 Affiliations 1 Department of Pharmaceutical Chemistry , University of Kansas , 2095 Constant Avenue , Lawrence , Kansas 66047 , United States.Acute B-Cell Inhibition by Soluble Antigen Arrays is Valency-Dependent and Predicts Immunomodulation in Splenocytes J. Daniel Griffin1, Martin A. Leon2, Jean R. Salash3, Michael Shao4, Brittany L. Hartwell1, Chad J. Pickens3, Joshua O. Sestak3, Cory Berkland1,3,4 1Bioengineering Graduate Program, University of Kansas, Lawrence, KS 2Department of Chemistry, University of Kansas, Lawrence, KSpH-responsive microgels are crosslinked polymer colloid particles that swell when the pH approaches the pK a of the polybase or polyacid chains. Poly(vinylamine) (PVAM) has the highest primary amine content of all amine-containing polymers.Despite much effort the preparation of colloidally stable PVAM microgels is still elusive.Congratulations to our collaborator, Prof. Cory Berkland, who was recognized last week with the Jim Baxendale Commercialization Award! Prof. Berkland...Biography —. Distinguished Professor of Chemical and Petroleum Engineering and Pharmaceutical Chemistry.Aug 2, 2016 · Fang WB, Yao M, Jokar I, Alhakamy N, Berkland C, Chen J, Brantley-Sieders D, Cheng N. The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells. Breast Cancer Res Treat. ... Cory J. Berkland,1,4 Cato T. Laurencin,2,3,5 and Michael S. Detamore6. 1Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66045 ...Settimio Pacelli, Sayantani Basu, Jonathan Whitlow, Aparna Chakravarti, Francisca Acosta, Arushi Varshney, Saman Modaresi, Cory Berkland, Arghya Paul. Strategies to develop endogenous stem cell-recruiting bioactive materials for tissue repair and regeneration. Advanced Drug Delivery Reviews 2017, 120, 50-70. DOI: 10.1016/j.addr.2017.07.011.Fah Chueahongthong; Singkome Tima; Sawitree Chiampanichayakul; Cory Berkland; Songyot Anuchapreeda: 1-Jan-2022 ...In recent history, through the merger of engineering and biological sciences, biotechnology has pressed toward improving methods for regenerating tissues, developing biosensors, and effectively delivering therapeutic agents.1. Peek LJ, Middaugh CR, Berkland C. Nanotechnology in vaccine delivery. Adv Drug Deliv Rev. 2008 May 22; 60(8):915–928. † We reviewed the field of nanotechnology applied to vaccine formulation and delivery in 2008. 2. O’Hagan DT, Fox CB. New generation adjuvants–from empiricism to rational design. Vaccine. 2015 Jun 8; 33(Suppl 2):B14 ...Berkland C, Kim K, Pack DW. PLG microsphere size controls drug release rate through several competing factors . Pharmaceutical Research . 2003 Jul 1;20(7):1055-1062. doi: 10.1023/A:1024466407849Cory Berkland Solon E. Summerfield Distinguished Professor School of Pharmacy, Pharmaceutical Chemistry Contact Info Email: [email protected] Phone: 785-864-1455 320E Multidisciplinary Research Building Lawrence 2030 Becker Drive Lawrence, KS 66047 Personal Links Cory Berkland Research Education —864-1455, Fax: (785) 864-1454, [email protected]. ‡Authors contributed equally to this work Supporting Information Figure S1. HSQC NMR data for DEX-N3. Figure S2. Levels of IFN-γ at peak of disease. Figure S3. Levels of IL-6 at peak of disease. Figure S4. Levels of IL-15 at peak of disease. Figure S5. Levels of IL-17A at peak of disease ...Abstract. Lung surfactant is crucial for optimal pulmonary function throughout life. An absence or deficiency of surfactant can affect the surfactant pool leading to respiratory distress. Even if the coupling between surfactant dysfunction and the underlying disease is not always well understood, using exogenous surfactants as replacement is ...
The most common forms of proteosomes used for vaccine applications are nanoparticles composed of the outer membrane proteins (OMPs) of Neisseria meningitidis. OMPs have been used successfully in a marketed meningococcal vaccine since 1981 and are considered non-toxic and well-tolerated [160], [161].Cory Berkland. [email protected]; Department of Chemical & Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047. Department of Chemical & Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047===Search for more papers by this authorJonathan Miller and Cory Berkland discovered and provisionally patented the soft 3D force sensing technology while working on federally funded smart materials research at the …Co-Founder & Chief Executive Officer at Context Therapeutics. Mr. Lehr is the Co-founder and CEO of Context Therapeutics. In addition, Mr. Lehr is a member of the Scientific Advisory Board of Integral Molecula r, an antibody discovery company. Previously, Martin was part of the founding team at Osage University Partners, a venture capital fund focused on academic spinouts from leading research ...
He received MS and PhD degrees from the Department of Chemical and Biomolecular Engineering at the University of Illinois in Urbana-Champaign and a BS degree in Chemical Engineering from Iowa State University in Ames. Prof. Berkland is a co-founder of Orbis Biosciences, Savara Pharmaceuticals, Bond Biosciences and Orion BioScience. 19/01/2021 ... Cory Berkland;. Cory Berkland. 2Department of Pharmaceutical Chemistry ... Cory Berkland,. Remi J. Creusot. Table S1 . List of antibodies used to ...Berkland C, Kim K, Pack DW. PLG microsphere size controls drug release rate through several competing factors . Pharmaceutical Research . 2003 Jul 1;20(7):1055-1062. doi: 10.1023/A:1024466407849…
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Cory Berkland is a professor in the Engineering department at Un. Possible cause: Diaz is a scholar in the IMSD program, and she is mentored by Cory Berkland, the Solon E.
Europe PMC is an archive of life sciences journal literature.Cory Berkland 1 , C Russell Middaugh 2 Affiliations 1 a Department of Chemical and Petroleum Engineering and Department of Pharmaceutical Chemistry , The University of Kansas , Lawrence , KS , USA.
C. Berkland, K. Kim, and D.W. Pack (2004) Controlling double-walled microcapsule shell thickness offers modulated piroxicam release Journal of Biomedical Materials Research 70A(4):576-584 C. Berkland, K. Kim, and D.W. Pack (2004) Uniform double-walled polymer microspheres of controllable shell thickness Journal of Controlled Release, 96(1):101-111Cory Berkland Professor Biomedical Engineering [email protected] Google Scholar Education PhD, University of Illinois, 2003 MS, University of Illinois, 2001 BS, Iowa State University, 1998 Research areas Advanced Materials Biomedical, Bio-inspired, and Bio-derived Materials Cell & Molecular Bioengineering Regenerative Engineering in Medicine
The aim of this project was to develop a ge What We Do. Our lab works at the interface of medicine and engineering with an emphasis on precisely controlling the physical and chemical properties of particles and biomaterials. The lab environment fosters multidisciplinary interaction between graduate and undergraduate researchers from the departments of Chemical and Petroleum Engineering ... The induction of immune response by presentation of antigen on or with immune stimulating “signal” is a primary design metric of vaccines. We rationalized that a similar strategy could also be used to design antigen-SITs to induce tolerance to autoantigen. Both approaches focus on the recognition, attack, and removal of a “foreign ... Dr. Cory Berkland Solon E. Summerfield DCory Berkland. Corresponding Author. E-mail address: be A method of forming particles comprises accelerating a stream comprising a liquid; and vibrating the stream, to form particles. The particle may have a diameter that is smaller than the diameter of the nozzle used to form the stream, allowing for the formation of micro- and nano-sized particle. Jian Qian, Bradley P. Sullivan, Samuel J. Peterson May 5, 2019 · Hartwell BL; Pickens CJ; Leon M; Berkland C, Multivalent Soluble Antigen Arrays Exhibit High Avidity Binding and Modulation of B Cell Receptor-Mediated Signaling to Drive Efficacy against Experimental Autoimmune Encephalomyelitis. Biomacromolecules 2017, 18 (6), 1893–1907. [PMC free article] [Google Scholar] May 4, 2017 · LAWRENCE — Cory Berkland might not be the first person you’d guess would help to create what has become a multimillion-dollar company. The distinguished professor, appointed in the departments of Pharmaceutical Chemistry and Chemical & Petroleum Engineering at the University of Kansas, grew up on a pig farm in Iowa, studied chemical engineering at the undergraduate and graduate levels and ... ensures that you are connecting to the offic2.1. Determination of Cytotoxicity of DoVisit the main Washington University in St. Lo 30/03/2016 ... Cory Berkland; Dr. S. Connor Dennis; Dr. Michael Detamore. References ... Cory J Berkland. Google. S Connor Dennis · Jon Whitlow · Michael S ... My research under Dr. Cory Berkland involved the de He received MS and PhD degrees from the Department of Chemical and Biomolecular Engineering at the University of Illinois in Urbana-Champaign and a BS degree in Chemical Engineering from Iowa State University in Ames. Prof. Berkland is a co-founder of Orbis Biosciences, Savara Pharmaceuticals, Bond Biosciences and Orion BioScience. Cory Berkland Magnetic nanoparticles that display high s[Gehrke, Professor Cory Berkland, Professor Kevin Leonard, and PCory Berkland. E-mail: [email protected]; Vladimir Birman Associate Calcium-crosslinked LABL-TAT complexes effectively target gene delivery to ICAM-1 expressing cells Supang Khondee1, Abdulgader Baoum1, Teruna J. Siahaan1, and Cory Berkland1,2,* 1Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS 66047 2Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, KSCory Berkland The University of Kansas Verified email at ku.edu. ... N Kobayashi, C Berkland, ... Journal of pharmaceutical sciences 95 (9), 1856-1872, 2006. 182: 2006: Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors. ME Anderson, TJ Siahaan.